Treatment-related changes in urinary excretion of high and low molecular weight proteins in patients with idiopathic membranous nephropathy and renal insufficiency

Nephrology Dialysis Transplantation

Volumn 21, Issue 2, 2006, Pages 389-396

  du Buf Vereijken, Peggy W G ^a,b   Wetzels, Jack F M ^b  

^a AMPHIA HOSPITAL   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

1 microglobulin; Immunosuppressive therapy; Membranous nephropathy; Renal insufficiency; Urinary ; Urinary 2 microglobulin; Urinary IgG

Indexed keywords

ALPHA 1 MICROGLOBULIN; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ATENOLOL; ATORVASTATIN; BETA 2 MICROGLOBULIN; BICARBONATE; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CAPTOPRIL; CIMETIDINE; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXAZOSIN; ENALAPRIL; IMMUNOGLOBULIN G; IRBESARTAN; LISINOPRIL; LOSARTAN; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; PERINDOPRIL; PREDNISONE; QUINAPRIL; RAMIPRIL; SIMVASTATIN; SPIRONOLACTONE; STEROID; UNINDEXED DRUG; VERAPAMIL;

ACCURACY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; GLOMERULUS FILTRATION; HUMAN; INTERSTITIAL NEPHRITIS; KIDNEY FAILURE; KIDNEY TUBULE ABSORPTION; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MOLECULAR WEIGHT; NEPHROSIS; NORMAL VALUE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN URINE LEVEL; PROTEINURIA; REMISSION; URINARY EXCRETION;

AGED; ALBUMINS; ALPHA-GLOBULINS; BETA 2-MICROGLOBULIN; CYCLOPHOSPHAMIDE; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS, MEMBRANOUS; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULIN G; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PREDNISOLONE; RENAL INSUFFICIENCY; TIME FACTORS;

EID: 31544432519     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfi219     Document Type: Article

References (20)

1. Haas M, Meehan SM, Karrison TG, Spargo BH. Changing etiologies of unexplained adult nephrotic syndrome: A comparison of renal biopsy findings from 1976-1979 and 1995-1997. Am J Kidney Dis 1997; 30: 621-631
2. Donadio JV Jr, Torres VE, Velosa JA et al. Idiopathic membranous nephropathy: The natural history of untreated patients. Kidney Int 1988; 33: 708-715
3. Schieppati A, Mosconi L, Perna A et al. Prognosis of untreated patients with idiopathic membranous nephropathy. N Engl J Med 1993; 329: 85-89
4. Ponticelli C, Zucchelli P, Passerini P et al. A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Kidney Int 1995; 48: 1600-1604
5. Reichert LJ, Koene RA, Wetzels JF. Urinary IgG excretion as a prognostic factor in idiopathic membranous nephropathy. Clin Nephrol 1997; 48: 79-84
6. Reichert LJ, Koene RA, Wetzels JF. Urinary excretion of beta 2-microglobulin predicts renal outcome in patients with idiopathic membranous nephropathy. J Am Soc Nephrol 1995; 6: 1666-1669
7. Branten AJ, du Buf-Vereijken PW, Klasen IS et al. Urinary excretion of β2-microglobulin and IgG predict prognosis in idiopathic membranous nephropathy: A validation study. J Am Soc Nephrol 2005; 16: 169-174
8. Bazzi C, Petrini C, Rizza V et al. Urinary excretion of IgG and alpha-1-microglobulin predicts clinical course better than extent of proteinuria in membranous nephropathy. Am J Kidney Dis 2001; 38: 240-248
9. Myers BD, Guasch A. Selectivity of the glomerular filtration barrier in healthy and nephrotic humans. Am J Nephrol 1993; 13: 311-317
10. Magil AB. Tubulointerstitial lesions in human membranous glomerulonephritis: Relationship to proteinuria. Am J Kidney Dis 1995; 25: 375-379
11. D'Amico G, Ferrario F, Rastaldi MP. Tubulointerstitial damage in glomerular-diseases - its role in the progression of renal damage. Am J Kidney Dis 1995; 26: 124-132
12. D'Amico G, Bazzi C. Pathophysiology of proteinuria. Kidney Int 2003; 63: 809-825
13. Branten AJ, Wetzels JF. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Clin Nephrol 2001; 56: 1-9
14. du Buf-Vereijken PW, Branten AJ, Wetzels JF. Cytotoxic therapy for membranous nephropathy and renal insufficiency: Improved renal survival but high relapse rate. Nephrol Dial Transplant 2004; 19: 1142-1148
15. Christensen CK, Mogensen CE, Hanberg SF. Renal function and cimetidine. Urinary albumin and beta 2-microglobulin excretion and creatine clearance during cimetidine treatment. Scand J Gastroenterol 1981; 16: 129-134
16. Jacobs EM, Vervoort G, Branten AJ et al. Atrial natriuretic peptide increases albuminuria in type I diabetic patients: Evidence for blockade of tubular protein reabsorption. Eur J Clin Invest 1999; 29: 109-115
17. Branten AJ, Wetzels JF. Influence of albumin infusion on the urinary excretion of beta2-microglobulin in patients with proteinuria. Nephron 1999; 81: 329-333
18. Thomas DM, Hillis AN, Coles GA, Davies M, Williams JD. Enalapril can treat the proteinuria of membranous glomerulonephritis without detriment to systemic or renal hemodynamics. Am J Kidney Dis 1991; 18: 38-43
19. Campbell R, Sangalli F, Perticucci E et al. Effects of combined ACE inhibitor and angiotensin II antagonist treatment in human chronic nephropathies. Kidney Int 2003; 63: 1094-1103
20. Lee TM, Su SF, Tsai CH. Effect of pravastatin on proteinuria in patients with well-controlled hypertension. Hypertension 2002; 40: 67-73